Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen Van der Borght

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
BMC Bioinformatics|March 28, 2014
Multi-model inference using mixed effects from a linear regression based genetic algorithmKoen Van der Borght, Geert Verbeke, Herman van Vlijmen
Journal of Virological Methods|August 6, 2009
Clinical cut-offs for HIV-1 phenotypic resistance estimates: update based on recent pivotal clinical trial data and a revised approach to viral mixturesBart Winters, Elke Van Craenenbroeck, Koen Van der Borght, et al.
Journal of Medical Virology|August 22, 2009
A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotypeMargriet Van Houtte, Gaston Picchio, Koen Van Der Borght, et al.
Scientific Reports|December 22, 2017
BIGL: Biochemically Intuitive Generalized Loewe null model for prediction of the expected combined effect compatible with partial agonism and antagonismKoen Van der Borght, Annelies Tourny, Rytis Bagdziunas, et al.
Virology Journal|January 4, 2013
Quantitative prediction of integrase inhibitor resistance from genotype through consensus linear regression modelingKoen Van der Borght, Ann Verheyen, Maxim Feyaerts, et al.
BMC Bioinformatics|November 12, 2015
QQ-SNV: single nucleotide variant detection at low frequency by comparing the quality quantilesKoen Van der Borght, Kim Thys, Yves Wetzels, et al.
Bioinformatics (Oxford, England)|September 3, 2014
VirVarSeq: a low-frequency virus variant detection pipeline for Illumina sequencing using adaptive base-calling accuracy filteringBie M P Verbist, Kim Thys, Joke Reumers, et al.
BMC Bioinformatics|October 5, 2011
Cross-validated stepwise regression for identification of novel non-nucleoside reverse transcriptase inhibitor resistance associated mutationsKoen Van der Borght, Elke Van Craenenbroeck, Pierre Lecocq, et al.
AIDS Research and Therapy|October 19, 2010
A comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus full sequencesKim Steegen, Michelle Bronze, Elke Van Craenenbroeck, et al.
Antiviral Research|June 15, 2011
Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitorOlivia Goethals, Marcia Van Ginderen, Ann Vos, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
BMC Bioinformatics|March 28, 2014
Multi-model inference using mixed effects from a linear regression based genetic algorithmKoen Van der Borght, Geert Verbeke, Herman van Vlijmen
Journal of Virological Methods|August 6, 2009
Clinical cut-offs for HIV-1 phenotypic resistance estimates: update based on recent pivotal clinical trial data and a revised approach to viral mixturesBart Winters, Elke Van Craenenbroeck, Koen Van der Borght, et al.
Journal of Medical Virology|August 22, 2009
A comparison of HIV-1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotypeMargriet Van Houtte, Gaston Picchio, Koen Van Der Borght, et al.
Scientific Reports|December 22, 2017
BIGL: Biochemically Intuitive Generalized Loewe null model for prediction of the expected combined effect compatible with partial agonism and antagonismKoen Van der Borght, Annelies Tourny, Rytis Bagdziunas, et al.
Virology Journal|January 4, 2013
Quantitative prediction of integrase inhibitor resistance from genotype through consensus linear regression modelingKoen Van der Borght, Ann Verheyen, Maxim Feyaerts, et al.
BMC Bioinformatics|November 12, 2015
QQ-SNV: single nucleotide variant detection at low frequency by comparing the quality quantilesKoen Van der Borght, Kim Thys, Yves Wetzels, et al.
Bioinformatics (Oxford, England)|September 3, 2014
VirVarSeq: a low-frequency virus variant detection pipeline for Illumina sequencing using adaptive base-calling accuracy filteringBie M P Verbist, Kim Thys, Joke Reumers, et al.
BMC Bioinformatics|October 5, 2011
Cross-validated stepwise regression for identification of novel non-nucleoside reverse transcriptase inhibitor resistance associated mutationsKoen Van der Borght, Elke Van Craenenbroeck, Pierre Lecocq, et al.
AIDS Research and Therapy|October 19, 2010
A comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus full sequencesKim Steegen, Michelle Bronze, Elke Van Craenenbroeck, et al.
Antiviral Research|June 15, 2011
Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitorOlivia Goethals, Marcia Van Ginderen, Ann Vos, et al.
Pageof 2